EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Incidence and prevalence of immune-mediated extraintestinal manifestations in paediatric inflammatory bowel disease: a systematic review and meta-analysis

Ruben J Colman iD, Sudheer K Vuyyuru, Virginia Solitano iD, John K MacDonald, Jessica Le, Amanda Ricciuto, Roberta Berard iD, Javed A Mohammed, Christopher Ma iD, Vipul Jairath iD, Eileen Crowley iD

Crohn's & Colitis 360 · 30.03.2026

DOI: 10.1093/crocol/otag024 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Crohn's & Colitis 360, online erschienen am 30.03.2026. Verfasst von Ruben J Colman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University School of Medicine, Stanford, CA, Uni…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune-mediated extraintestinal manifestations (IM-EIMs) are common in paediatric inflammatory bowel disease (pIBD). This systematic review and meta-analysis aimed to summarise the incidence and prevalence of IM-EIMs in pIBD.

Methods

MEDLINE, EMBASE, CENTRAL and clinicaltrials.gov were searched up to May 6, 2024, for studies that included pIBD (2-17 years) patients diagnosed with IM-EIMs. Primary outcomes included the incidence and prevalence of IM-EIMs among pIBD. Meta-analysis included pooled proportions of prevalence with DerSimonian-Laird random-effects analysis.

Results

The pooled proportion of IM-EIMs among pIBD overall was 10% (95% CI, 8-12%; I2=97.2%) among 65 studies (35,343 patients). The pooled proportion of IM-EIMs was 10% (95% CI, 7-13%; I2=94.8%) among 37 Crohn’s disease (CD) studies (7657 patients), compared to 11% (95% CI, 7-15%; I2=93.3%) among 39 ulcerative colitis (UC) studies (4698 patients). Enthesitis was the highest reported individual IM-EIM (23%, 95% CI, 4-50%; I2=94.7%) in pIBD. Arthritis was the second highest reported individual IM-EIM (8%, 95% CI, 6-10%; I2=96%) in pIBD, followed by primary sclerosing cholangitis (PSC) in UC (5%, 95% CI, 4-7%; I2=81%). Uveitis, pyoderma gangrenosum, autoimmune hepatitis and PSC in CD were the lowest reported IM-EIMs at 1% or less. The largest difference in proportions between IBD phenotypes was PSC, which was 4% higher in UC than CD.

Conclusions

While musculoskeletal manifestations are common, fewer than 5% of pIBD patients experience ophthalmological, dermatological, and liver IM-EIMs. The small number of studies resulted in significant methodological and statistical heterogeneity. Multicentre collaborative efforts are needed to systematically describe the epidemiology of IM-EIMs in pIBD.

Schlagwörter

Stichwörter der Autor:innen

immune-mediated extraintestinal manifestationsincidencepediatric inflammatory bowel diseaseprevalence

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University School of Medicine, Stanford, CA, United States.
  • Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University, London, ON, Canada.
  • Alimentiv Inc., London, ON, Canada.
  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy.
  • Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
  • Division of Gastroenterology, Hepatology and Nutrition, SickKids Inflammatory Bowel Disease Centre, The Hospital for Sick Children, Toronto, ON, Canada.

ORCID-Profile: Ruben J Colman, Virginia Solitano, Roberta Berard, Christopher Ma, Vipul Jairath, Eileen Crowley

Zitieren

APA

Colman, R. J., Vuyyuru, S. K., Solitano, V., MacDonald, J. K., Le, J., Ricciuto, A., Berard, R., Mohammed, J. A., Ma, C., Jairath, V., & Crowley, E. (2026). Incidence and prevalence of immune-mediated extraintestinal manifestations in paediatric inflammatory bowel disease: a systematic review and meta-analysis. Crohn's & Colitis 360. https://doi.org/10.1093/crocol/otag024

Vancouver

Colman RJ, Vuyyuru SK, Solitano V, MacDonald JK, Le J, Ricciuto A, et al. Incidence and prevalence of immune-mediated extraintestinal manifestations in paediatric inflammatory bowel disease: a systematic review and meta-analysis. Crohn's & Colitis 360. 2026. doi:10.1093/crocol/otag024

BibTeX
@article{Colman2026,
  author = {Colman, Ruben J and Vuyyuru, Sudheer K and Solitano, Virginia and MacDonald, John K and Le, Jessica and Ricciuto, Amanda and Berard, Roberta and Mohammed, Javed A and Ma, Christopher and Jairath, Vipul and Crowley, Eileen},
  title = {Incidence and prevalence of immune-mediated extraintestinal manifestations in paediatric inflammatory bowel disease: a systematic review and meta-analysis},
  journal = {Crohn's & Colitis 360},
  year = {2026},
  doi = {10.1093/crocol/otag024}
}
Kostenlos starten →